News & Articles

The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples

New findings pave way to potentially improved assessment of measurable residual disease in AML patients

The research describes a new family of enzymes for pharmaceutical production

The Allplex SARS-CoV-2 Master Assay can detect a total of 10 targets including four coronavirus genes

Seegene’s new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 min

Dr. Boye Schnack Nielsen shares tips for running successful in situ hybridization assays as he provides insights on how RNA detection methods have evolved over time

The antigen test is used to detect the nucleocapsid protein antigen in SARS-CoV-2

Industry-leading 3D ligand-based design approaches from BioPharmics will be available in StarDrop, Optibrium’s small molecule design and optimization software

Innovation and growth remain a priority to support customers and COVID-19 initiatives

The Simplexa™ SARS-CoV-2 Variants Direct assay aims to enable detection of four mutations associated with virus variants without requiring upfront RNA extraction

The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods

Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences

Genome editing experts harness the power of CRISPR-Cas enzymes to power the next diagnostic revolution in COVID-19 detection and diagnosis

Find out how to meet tough quality control and assurance regulations with the latest resources, new methods, and exclusive interviews

In this series of webinars, discover the latest techniques and technologies helping researchers advance their biopharmaceuticals workflows

Catch up on this expert webinar to discover the customizable screening service helping to drive the validation of novel cancer therapies

Extension aims to evaluate CN Bio’s PhysioMimix lung-on-a-chip platform in addition to deepening existing research collaboration for liver studies

KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology

Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems